Sanofi - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SNY Nasdaq 2834 www.sanofi.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sanofi

Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi - Jul 19th, 2025 10:35 pm
Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock? - Jul 18th, 2025 7:54 am
Adult-onset Still Disease Market Research Report 2025-2035 | Personalized Medicine and Biomarker Discoveries Enhance Treatment Outcomes - Jul 18th, 2025 5:35 am
Fabry Disease Treatment Analysis Report 2025 | Market to Reach $3.86 Billion by 2030, Rising Fabry Disease Prevalence and Demand for Targeted Therapies Drive Growth - Jul 18th, 2025 4:57 am
Press Release: Sanofi completes acquisition of Blueprint Medicines - Jul 17th, 2025 11:00 pm
Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear - Jul 17th, 2025 7:00 am
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - Jul 17th, 2025 3:25 am
Press Release: Sanofi announces extension of Blueprint tender offer - Jul 16th, 2025 11:00 pm
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag - Jul 16th, 2025 9:54 am
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Jul 16th, 2025 7:58 am
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - Jul 16th, 2025 7:35 am
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - Jul 16th, 2025 6:00 am
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration - Jul 15th, 2025 11:00 pm
Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More - Jul 15th, 2025 3:26 am
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Jul 14th, 2025 6:51 am
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements - Jul 14th, 2025 4:04 am
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports - Jul 12th, 2025 7:36 am
Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding - Jul 10th, 2025 12:30 am
Morgan Stanley Assumes Coverage of Kymera Therapeutics (KYMR) Stock with Overweight Rating - Jul 9th, 2025 10:39 pm
CTO East Coast 2025: AI can speed up all parts of clinical trial ecosystem - Jul 9th, 2025 2:23 pm